Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Cash flows from operating activities:
Net loss	$ (1,612,953)	$ (793,195)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	23,966	12,792
Amortization of patents	13,253	13,252
Stock compensation	30,715	56,988
Employee bonus paid in stock	171,046
Loss (Income) from earnings on China joint venture		(9,564)
Change in fair value of derivative liability		(40,260)
Non-cash operating lease expense	27,627
Changes in operating assets and liabilities:
Decrease in accounts receivable	421,127	465,710
Decrease in accounts receivable, related party		50,000
Decrease in other receivables	11,755	9,523
(Increase) decrease in inventories	(102,316)	59,760
(Increase) decrease in advances on contracts	(65,171)	118,669
Increase in prepaid expenses and other current assets	(165,032)	(181,410)
(Decrease) increase in accounts payable	64,317	(6,772)
(Decrease) increase in accounts payable, related party	30,567	(263,043)
Decrease in deferred cost, related party		25,398
Increase in accrued expenses	255,426	182,638
(Decrease) increase in accrued expenses, related party	(76,406)	110,215
(Decrease) in deferred revenue, related party		(50,000)
Net cash used in operating activities	(971,079)	(220,171)
Cash flows from investing activities:
Purchase of property and equipment	(7,138)	(8,104)
Net cash used in investing activities	(7,138)	(8,104)
Cash flows from financing activities:
Proceeds from exercise of warrants	230,362
Payments of finance leases	(2,252)
Net proceeds from Public Placement Offering		1,974,546
Net proceeds from Private Placement Offering		250,000
Net cash provided by financing activities	228,920	2,224,546
Net increase (decrease) in cash and cash equivalents	(750,297)	2,035,826
Cash and cash equivalents at beginning of period	1,516,272	1,996,271
Cash and cash equivalents at end of period	765,975	2,739,700
Supplemental non-cash disclosure of cash flow information:
Shares issued to board of directors		61,500
Shares issued to board of directors for services rendered		7,500
Shares issued to employees for compensation	182,500	7,000
Shares issued to consultants in lieu of cash payments	25,000	40,000
Initial recognition of operating lease-right of use assets	706,251	166,292
Initial recognition of operating lease right to used liabilities	(706,251)	(166,292)
Derivative liability		$ (406,045)